Carmen M. Anadon

ORCID: 0000-0002-8851-4545 · 2 papers in corpus

article 2023

Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma

Gynecologic oncology ·doi:10.1016/j.ygyno.2023.03.020

OBJECTIVE: To demonstrate that shared antibody responses in endometriosis and endometriosis-associated ovarian cancer spontaneously antagonize malignant progression and can be leveraged to develop future immunotherapies. METHODS: B cells f…

article 2022

Utilization of immortalized B cells to identify SDCBP as a novel therapeutic target in ovarian carcinoma.

·doi:10.1200/jco.2022.40.16_suppl.e14507

e14507 Background: We hypothesized that tumor-infiltrating B cells in endometriosis and endometriosis-associated ovarian cancer can be used to identify novel, targetable antigen domains to inhibit the progression of ovarian carcinomas. We a…